Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

The possible role of receptor-ligand pairs on B cells in expansion of malignant B cell clone in B-CLL (CROSBI ID 531829)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Dašić, Gorana ; Gagro, Alenka ; Rabatić, Sabina ; Sabioncello, Ante ; Vitale, Branko The possible role of receptor-ligand pairs on B cells in expansion of malignant B cell clone in B-CLL // Immunobiology, 194 (1-3). 1995. str. 282-282-x

Podaci o odgovornosti

Dašić, Gorana ; Gagro, Alenka ; Rabatić, Sabina ; Sabioncello, Ante ; Vitale, Branko

engleski

The possible role of receptor-ligand pairs on B cells in expansion of malignant B cell clone in B-CLL

B cell chronic lymphocyte leukemia (B-CLL) is lymphoproliferative syndrome characterized by an expansion of long-lived, small, non-dividing CD5+ B cell malignant clone which din not retain the capacity to functionally maturate and underwent programmed cell death. In this study we proposed that B cell homotypic adhesion in B-CLL might contribute to that malignant cell gathering. In regard to better evaluate the presence of CD5/CD72 and CD21/CD23 molecule ligand pairs on B cells in B-CLL patients, we performed whole blood three-color immunofluorescence analysis to detect the B cells (CD19) wich are simultaneously CD5+CD72+ and CD21+CD23+. Heparinized whole blood samples were obtained from 32 B-CLL patients and from 19 age and gender matched controls. We found the percentage of CD5+, CD72+, and CD23+ B cells to be significantly increased in the patient group, whereas the percentage of CD21+ B cells did not differ from control values. In conclusion, the increased expression of CD19+CD5+CD72+ and CD19+CD21+CD23+ on leukemic B cells may facilitate and contribute to accumulation of malignant C cell clone.

immunophenotyping; CD19; CD5; CD21; CD23; CD72

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

282-282-x.

1995.

objavljeno

Podaci o matičnoj publikaciji

Podaci o skupu

Joint Annual Meeting Osterreichische Gesellschaft fur Allergologie und Immunologie and Gesellschaft fur Immunologie

poster

27.09.1995-30.09.1995

Beč, Austrija

Povezanost rada

Temeljne medicinske znanosti, Kliničke medicinske znanosti